BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 7834439)

  • 21. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy.
    Moran M; Haffty BG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):353-8. PubMed ID: 9457821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lobular neoplasia on core needle biopsy does not require excision.
    Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
    Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
    King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
    J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.
    Abner AL; Connolly JL; Recht A; Bornstein B; Nixon A; Hetelekidis S; Silver B; Harris JR; Schnitt SJ
    Cancer; 2000 Mar; 88(5):1072-7. PubMed ID: 10699897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
    Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
    Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
    De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
    Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?
    Ibrahim N; Bessissow A; Lalonde L; Mesurolle B; Trop I; Lisbona A; El-Khoury M
    AJR Am J Roentgenol; 2012 Feb; 198(2):288-91. PubMed ID: 22268170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
    Berg WA; Mrose HE; Ioffe OB
    Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility.
    Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL
    AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
    Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
    Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy.
    Rosen PP; Braun DW; Lyngholm B; Urban JA; Kinne DW
    Cancer; 1981 Feb; 47(4):813-9. PubMed ID: 7226031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS).
    Fowble B; Hanlon AL; Fein DA; Hoffman JP; Sigurdson ER; Patchefsky A; Kessler H
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):949-57. PubMed ID: 9276359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience.
    Hoffman DI; Zhang PJ; Tchou J
    Surg Oncol; 2019 Mar; 28():190-194. PubMed ID: 30851899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.